FSI Stanford Publications

Cost-Effectiveness of a Potential Vaccine for Human Papillomavirus

Journal Article

Authors
Gillian D. Sanders - Stanford University
AV Taira

Published by
Emerging Infectious Diseases, January 8, 2003

Topics: Health policy

Publications of interest

Cost-Effectiveness of Potential Vaccine for Cocciodiodes immitis
AE Barnato, Gillian D. Sanders, Douglas K. Owens
Emerging Infectious Diseases vol. 7, 5 (2001)
Cost-Effectiveness of a Potential Prophylactic Helicobacter pylori Vaccine in the United States.
Rupnow MF, Chang AH, Ross D. Shachter, Douglas K. Owens, Julie Parsonnet
Journal of Infectious Disease vol. 200 (2009)
Evaluating Human Papillomavirus Vaccination Programs
Al Taira, Kristof Neukermans, Gillian D. Sanders
Emerging Infectious Diseases vol. 10, 11 (2004)
Cost-Effectiveness of the Pneumococcal Vaccine in Healthy Younger Adults
PV Pepper, Douglas K. Owens
Medical Decision Making vol. 22 (suppl), 5 (2002)

Cost-Effectiveness Analyses: Evaluation of Potential Human Papillomavirus Vaccine Rollout Strategies Using a Dynamic Transmission Model
Al Taira, Gillian D. Sanders
The Cost-Effectiveness of a Potential HPV Vaccine
Gillian D. Sanders
Cost-Effectiveness Analyses: Cost-Effectiveness of Vaccinating College Freshmen against Meningitis
Gillian D. Sanders, P Bilir, C Rydzak
Clopidogrel Versus Aspirin for Secondary Prophylaxis of Thrombotic Events: A Cost-Effectiveness Analysis
Mark Schleinitz